Myogenic regulatory transcription factors regulate growth in rhabdomyosarcoma
Inês M. Tenente(Universidade do Porto), David M. Langenau(Massachusetts General Hospital), G. Petur Nielsen(Harvard University), Javed Khan(Kent State University), Madeline N. Hayes(Oregon Health & Science University), Marielle E. Yohe(National Cancer Center), Mariana L. Oliveira(University of Lisbon), Sivasish Sindiri(National Institutes of Health), Myron S. Ignatius(The University of Texas at San Antonio Health Science Center), Ashwin Ramakrishnan(Princess Margaret Cancer Centre), Karin M. McCarthy(Harvard University), Eleanor Y. Chen(University of Washington), Qin Tang(University of Electronic Science and Technology of China), Berkley E. Gryder(University School)
Cited by 74
Related Papers
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors
|Cancer Discovery|2014|789
Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome
|Blood|2011|638
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
|Nature Genetics|2015|563